In Reversal, FDA Opens Door To Morning-After Pill

Law360, New York (July 31, 2006, 12:00 AM EDT) -- A year after controversy erupted over the agency's refusal to make the morning-after pill available over-the-counter, the Food and Drug Administration unexpectedly announced Monday that it is considering allowing the drug to be sold without prescription to women over the age of 18.

Acting FDA Commissioner Dr. Andrew von Eschenbach said in a letter to Barr Pharmaceuticals—which makes Plan B through subsidiary Duramed Pharmaceuticals Inc.—that the agency would like to meet with company officials “as soon as practicable and preferably within seven days.”

He said the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.